MAPT and Alzheimer disease: Additionally, harmine and other β-carboline alkaloids—compounds structurally related to DMT—have shown the ability to reduce Tau phosphorylation at key residues such as S396, S262/S356, and T231 through inhibition of DYRK1A, a kinase implicated in AD pathology [10].